Press Releases

July 23, 2020
MONTREAL and CHARLOTTE, N.C. , July 23, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it has entered into a securities purchase agreement
Displaying 11 - 16 of 16
Print Page
RSS Feeds
Email Alerts
Investor Contact
Search